Immunotherapy in surgical cancer patients
Schackert, H.K.; Betzler, M.; Herfarth, C.
Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 59(5): 317-322
1988
ISSN/ISBN: 0009-4722 PMID: 3293943 Document Number: 314488
Document emailed within 1 workday
Related Documents
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113Takeda, T.; Nakamura, K.; Sato, M.; Takeda, T.; Tomimaru, Y.; Takeda, H. 2014: The effect of immunotherapy and hyperthermia on patients with advanced or recurrent cancer - analyses by cancer type and recurrence form Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(10): 1261-1263
Takeda, T.; Miyazawa, K.; Takeda, T.; Takeda, H.; Takeda, Y. 2010: Multidisciplinary therapy for 984 cancer patients--hyperthermic immunotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2243-2245
Gatenby, P.A.; Basten, A.; Tattersall, M.H.; Fox, R.M. 1980: Autoantibodies in cancer patients given Corynebacterium parvum/levamisole immunotherapy Lancet 1(8177): 1082
Nakamura, M.; Wada, J.; Suzuki, H.; Tanaka, M.; Katano, M.; Morisaki, T. 2009: Long-term outcome of immunotherapy for patients with refractory pancreatic cancer Anticancer Research 29(3): 831-836
Wada, J.; Yamasaki, A.; Nagai, S.; Yanai, K.; Fuchino, K.; Kameda, C.; Tanaka, H.; Koga, K.; Nakashima, H.; Nakamura, M.; Tanaka, M.; Katano, M.; Morisaki, T. 2008: Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients Anticancer Research 28(4c): 2401-2408
Kubo, M.; Morisaki, T.; Kuroki, H.; Tasaki, A.; Yamanaka, N.; Matsumoto, K.; Nakamura, K.; Onishi, H.; Baba, E.; Katano, M. 2003: Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer Anticancer Research 23(6a): 4443-4449
Toh, U.; Sudo, T.; Kido, K.; Tanaka, T.; Sueyoshi, S.; Fujita, H.; Hiraki, M.; Horiuchi, H.; Shirouzu, K.; Yamana, H. 2002: Intraarterial cellular immunotherapy for patients with inoperable liver metastases of esophageal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(12): 2152-2156
Kan, N.; Imamura, M. 1993: Loco-regional immunotherapy with OK-432 and cultured autologous lymphocytes for patients with metastatic cancer Human Cell 6(2): 100-105
Hadźiev, S.; Mandulova, P.; Kavaklieva-Dimitrova, J.; Penev, K.; Spassova, M.; Madźarova, S. 1982: BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis Neoplasma 29(1): 93-110
Nishikawa, H.; Yasaki, S.; Yoshimoto, T.; Sakatani, M.; Itoh, M.; Masuno, T.; Namba, M.; Ogura, T.; Hirao, F.; Azuma, I.; Yamamura, Y. 1978: Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy Gan 69(6): 819-824
De Boer, E.C.; De Jong, W.H.; Steerenberg, P.A.; Van der Meijden, A.P.; Aarden, L.A.; Debruyne, F.M.; Ruitenberg, E.J. 1991: Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin In Vivo 5(6): 671-677
Tanigawa, K.; Itoh, Y.; Kobayashi, Y. 2016: Improvement of QOL and Immunological Function with Lentinula Edodes Mycelia in Patients Undergoing Cancer Immunotherapy: An Open Pilot Study Alternative Therapies in Health and Medicine 22(4): 36-42
Luo, Y.; Chen, X.; Downs, T.M.; DeWolf, W.C.; O'Donnell, M.A. 1999: IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy Journal of Immunology 162(4): 2399-2405
Velotti, F.; Tubaro, A.; Stoppacciaro, A.; Pettinato, A.; Morrone, S.; Bossola, P.; Napolitano, T.; Miano, L.; Ruco, L.; Piccoli, M. 1990: Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase i study Annali Dell'istituto Superiore di Sanita 26(3-4): 411-421
Morton, D.L. 2004: Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma Developments in Biologicals 116: 209
Ismail, E.; Kornovski, Y.; Ivanov, S.; Kovachev, E.; Slavchev, S.; Tzonev, A. 2013: Oncologucal results after surgical and radio-surgical treatment in patients with cervical cancer stage Ib1 Akusherstvo i Ginekologiia 52(Suppl 1): 31-36
Izumi, M. 1993: Preoperative immunotherapy in patients with gastric cancer--with special reference to analysis with monoclonal antibodies of T-lymphocyte subsets and interleukin-2 oral administration of OK-432 (Picibanil) Nihon Geka Gakkai Zasshi 94(1): 27-32
Chretien, P.B.; Lipson, S.D.; Makuch, R.; Kenady, D.E.; Cohen, M.H.; Minna, J.D. 1978: Thymosin in cancer patients: in vitro effects and correlations with clinical response to thymosin immunotherapy Cancer Treatment Reports 62(11): 1787-1790
Lygidakis, N.J.; Pothoulakis, J.; Konstantinidou, A.E.; Spanos, H. 1995: Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study Anticancer Research 15(2): 543-550